Rossari Biotech Reports ₹317.02 Crore Profit in Q3 FY25, Revenue Up 10.5% YoY

Mumbai, January 28, 2025 – Rossari Biotech Limited (NSE: ROSSARI, BSE: 543213) has announced its Q3 FY25 financial results, reporting a 10.5% year-on-year (YoY) increase in total revenue, reaching ₹5,127.31 crore, while net profit stood at ₹317.02 crore, reflecting the company’s strong performance in specialty chemicals and sustainable solutions.

Key Financial Highlights – Q3 FY25 (Consolidated)​

For the nine months ended December 31, 2024 (9M FY25):

• Revenue: ₹15,007.32 crore (+10.5% YoY).
• Net Profit: ₹1,019.34 crore (+5.5% YoY).

Segment-Wise Performance & Business Highlights​

1. Specialty Chemicals Expansion & Revenue Growth​

• Textile & Performance Chemicals: Revenue increased by 12.4% YoY with demand for eco-friendly dyeing and finishing agents.
• Animal Health & Nutrition Division: 8.7% YoY growth, driven by higher exports and new product formulations.

2. Acquisition & International Expansion​

• New Subsidiary in Saudi Arabia: Rossari Biotech incorporated Rossari International Limited Company in Saudi Arabia to expand its footprint in the Middle East & Africa.
• New Step-Down Subsidiaries:
  • Rossari Biotech Trading FZE (Dubai) for global exports.
  • Unistar Thai Co. Ltd. (Thailand), acquired in December 2024, enhancing its presence in Southeast Asia.

3. Manufacturing & Capacity Expansion​

• Increased production capacity for high-value specialty chemicals at Dahej and Silvassa plants.
• Planned investments in R&D for green chemistry solutions and enzyme-based products.

Board Approvals & Corporate Actions​

1. Employee Stock Option Plan (ESOP) Issuance
   • 67,000 equity shares allotted at ₹2 per share under Rossari ESOP 2019.
2. Debt & Financial Health
   • No outstanding loan defaults or material debt repayments due in Q3 FY25.
   • Cash Reserves: ₹1,200 crore in liquidity, ensuring strong financial stability.

Management Commentary​

Edward Menezes, Executive Chairman, Rossari Biotech, stated:
"We are consistently expanding our presence in high-growth specialty chemical markets, supported by new global subsidiaries. Our long-term focus on sustainability, green chemistry, and innovation will continue to drive our leadership in the sector."

Strategic Outlook & Market Positioning​

• Continued investments in R&D for sustainable chemical solutions.
• Expansion in Middle East, Southeast Asia, and Africa to drive future revenue.
• Further acquisitions & capacity enhancements planned for FY26.

With robust revenue growth, international expansion, and a focus on sustainable innovation, Rossari Biotech remains a key player in India’s specialty chemicals industry.